Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 1 ~ 20 of 1688, Page 1 of 85
1. In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance
06/18/2019 WHO
2. Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation / Assay is the first and only rapid point-of-care test cleared by the U.S. Food and Drug Administration (FDA) to aid healthcare professionals in the diagnosis of diabetes
06/17/2019 Abbott
3. New Survey Shows Millennials Can Help Avoid Blood Shortages
45% of blood donations have historically come from people over 50 years old, but that number is declining / As more millennials bring their passion to blood donation, they can fill the gap left by aging baby boomers
06/13/2019 Abbott
4. Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
06/10/2019 Medtronic
5. Current Legal Cannabis Driving Limits in U.S., Europe Are Ineffective According to Breaking Research in AACC뭩 Clinical Chemistry Journal
New findings, published today in AACC뭩 Clinical Chemistry journal, add to a growing body of evidence suggesting that no legal driving limit for cannabis can catch impaired recreational users without unfairly penalizing unimpaired regular or medicinal users.
05/14/2019 AACC
6. Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., on efforts to promote and foster blood pathogen reduction technologies
03/26/2019 U.S. FOOD & DRUG ADMINISTRATION
7. Abbott''s Latest Diagnostics Technology, Alinity, Selected by Regional Medical Laboratory, Inc. to Deliver Benefits to Hospitals and Patients
Regional Medical Laboratory, Inc., which is part of the Ascension network, partners with Abbott, the global health leader, to advance lab capabilities and help improve health outcomes
03/05/2019 Abbott
8. FDA warns patients and doctors about recall of home-use test strips used with device to monitor blood thinner warfarin, not authorized for sale in U.S.
02/01/2019 U.S. FOOD & DRUG ADMINISTRATION
9. FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications
Risk Evaluation and Mitigation Strategy (REMS)
01/24/2019 U.S. FOOD & DRUG ADMINISTRATION
10. Japanese Red Cross Society Selects Abbott Technology to Screen Country''s Blood and Plasma Supply
LONG-TERM AGREEMENT BETWEEN JAPANESE RED CROSS SOCIETY AND ABBOTT BRINGS TOGETHER TWO GLOBAL LEADERS IN BLOOD AND PLASMA SCREENING, HELPING ENSURE A SAFE AND EFFICIENT BLOOD SUPPLY ACROSS JAPAN
01/17/2019 Abbott
11. FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk
Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in measuring nutrients in breast milk, including the concentration of fat, carbohydrate, protein, total solids and energy
12/21/2018 U.S. FOOD & DRUG ADMINISTRATION
12. Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled.
12/06/2018 U.S. FOOD & DRUG ADMINISTRATION
13. FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
12/04/2018 U.S. FOOD & DRUG ADMINISTRATION
14. FDA authorizes first test to aid in detecting a type of herpes virus in newborns called cytomegalovirus
11/30/2018 U.S. FOOD & DRUG ADMINISTRATION
15. Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on transformative new steps to modernize FDA’s 510(k) program to advance the review of the safety and effectiveness of medical devices
Modernizing the 510(k) Pathway“Safety and Performance Based Pathway” / Promoting Greater Transparency and Post-Market Surveillance
11/26/2018 U.S. FOOD & DRUG ADMINISTRATION
16. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs
11/16/2018 U.S. FOOD & DRUG ADMINISTRATION
17. Abbott and The Chertoff Group Explore Current State of Cybersecurity in the Connected Hospital
New White Paper Shares Research Findings on Perceptions and Awareness of Medical Device Cybersecurity, Need for Collaboration to Address Cybersecurity Challenges
11/15/2018 Abbott
18. AMA President Outlines Efforts to Attack Dysfunction in Health Care
11/14/2018 American Medical Association
19. FDA authorizes emergency use of first Ebola fingerstick test with portable reader
Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus).
11/09/2018 U.S. FOOD & DRUG ADMINISTRATION
20. New $15 Million Initiative to Further Reimagine Physician Training
New AMA Reimagining Residency initiative is aimed at transforming residency training to ensure physician well-being and improved patient safety.
10/30/2018 American Medical Association (AMA)
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱